We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Read about temporary adjustments to agri-environment scheme options and actions in 2024 due to wet weather.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
High needs reforms and savings targets have been agreed for local authorities with the highest dedicated school grant deficits.
The approach to including substances of very high concern on the UK REACH candidate list.
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
When and how you need to register your item or apply for an exemption certificate to deal in ivory.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Information for breast screening service staff about how to organise very high risk (VHR) screening as part of the NHS Breast Screening Programme (NHS BSP).
Globally, there has been a very small number of reports of new-onset or aggravation of pre-existing myasthenia gravis with atorvastatin, pravastatin, lovastatin, fluvastatin, simvastatin, rosuvastatin and pitavastatin (single-ingredient and fixed-dose combination products). Advise patients taking statins to be alert to...
Findings and lessons learnt to date from the 5G Testbeds and Trials Programme
Annual mid-year population estimates for people aged 90 years and over by sex and single year of age (90 to 104 years, and 105 years and over) and comparisons between UK countries.
People in the oldest age groups in the UK (90 to 104 and 105 and over) by sex and age, and comparisons of the oldest populations in the 4 constituent countries of the UK.
Annual mid-year population estimates for people aged 90 years and over by sex and single year of age (90 to 104) and 105 years and over and comparisons between UK countries.
We're seeking views on improving broadband for Very Hard to Reach premises.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.